Volume 14, Issue 12, December 2012

Resection of PCNSL, if safely possible, seems to be better than biopsy: challenging a paradigm?

• Extract
• View article

The molecular biology of WHO grade I astrocytomas

• Abstract
• View article

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group

• Abstract
• View article
• Supplementary data

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures

• Abstract
• View article
• Supplementary data

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

• Abstract
• View article
• Supplementary data

Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase–1 mutation

• Abstract
• View article

Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [¹⁸F]FET-PET imaging in intracranial WHO grade II and III gliomas

• Abstract
• View article

Surgery for primary CNS lymphoma? Challenging a paradigm

• Abstract
• View article

The effects of radiotherapy on psychosocial and cognitive functioning in adults with a primary brain tumor: a prospective evaluation

• Abstract
• View article
• Supplementary data

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

• Abstract
• View article

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

• Abstract
• View article

A phase I/II trial of vandetanib for patients with recurrent malignant glioma

• Abstract
• View article

Society news

• Extract
• View article

Erratum

• Extract
• View article

Contents Page

• View article

Cover Page

• View article

Editorial Board

• View article

Subscription Page

• View article